News from Zyme and the companies we work with.
Closed Loop Medicine appoints David Van Sickle as Non-Executive Director and Simon Ramsden as Chief Financial Officer
Appointments strengthen the Board and senior leadership team to support the Company’s international growth London, UK, 26 July 2022: Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription [...]
CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services Cambridge, UK, 19 July 2022: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and [...]
FUJIFILM Irvine Scientific Opens New Armstrong R&D Cell Culture Center of Excellence
Construction completed for expanded facility within California headquarters SANTA ANA, California, July 14, 2022: FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically [...]
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring
Highly Selective Recombinant Monoclonal Antibodies Targeting Brentuximab Vedotin, Secukinumab, and Their Biosimilars HERCULES, Calif. — July 12, 2022 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in [...]
Centauri Therapeutics strengthens senior leadership team with three key appointments
Dr Jennifer Schneider appointed CEO, Dr Helen Bright joins as VP of Research & Development, and Professor David Roblin will Chair the Board of Directors Senior appointments support acceleration of [...]
Ubiquigent appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board
Experts in structural biology and drug development will help exploit the deubiquitylase (DUB) enzyme family as new drug targets Dundee, UK, 5 July 2022: Ubiquigent Limited (Ubiquigent), a leading partner [...]
Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss
Cambridge, UK, Tokyo, Japan, 05 July 2022: Mogrify Limited (CEO: Darrin M. Disley, Ph.D., “Mogrify®”), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo [...]
LG Chem renews license triggering payment to Avacta
LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme London and Wetherby, UK, 30 June 2022: Avacta Group plc (AIM: AVCT), a [...]
Avacta announces second dose escalation in the Phase I clinical study of AVA6000 Pro-doxorubicin
London and Wetherby, UK, 29 June 2022: Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ [...]
Bio-Rad Launches EconoFit Chromatography Column Packs
Wide Selection of Resins in New, Convenient Column Format to Support the Development of Protein Purification Workflows HERCULES, Calif.—June 28, 2022—Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader [...]
H.E.L Group releases iso-BTC+ calorimeter for isothermal battery performance testing
New system offers performance testing on more powerful, larger batteries Iso-BTC+ will be launched at Battery Show Europe, Stuttgart (28-30 June), Battery Cells and Systems Expo in Birmingham (28-9 June) [...]
Bio-Rad Introduces CFX Opus Deepwell Real-Time PCR Detection System
System Offers Robust and Precise Quantification to Improve Nucleic Acid Detection for Larger Volume Assay Development HERCULES, Calif. — June 27, 2022 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), [...]
